{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:34Z","timestamp":1788303994727,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG2H0222"],"award-info":[{"award-number":["CMRPG2H0222"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytokines are effective molecules of immune reactions. They work in inflammatory sites as well as circulate in the blood. Cytokines in the cerebrospinal fluid have been suggested to be markers of autoimmune encephalitis and reflect disease progression. However, studies on blood cytokines in autoimmune encephalitis are scarce. We report a case presenting with serial changes in blood cytokine levels in a male patient with anti-contactin-associated protein 2 (Caspr2) encephalitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 61-year-old man without systemic disease presented with ataxia and speech disturbance 1\u00a0week. After admission, he further developed visual hallucinations, psychosis, and consciousness deterioration. Brain magnetic resonance imaging and infection and tumor surveillances were negative. 18F-fluorodeoxyglucose positron emission tomography of brain revealed frontal and occipital hypometabolism and anterior cingulate gyrus and mesial temporal hypermetabolism. Autoimmune studies confirmed Caspr2 antibodies in his blood. After receiving a diagnosis of anti-Caspr2 encephalitis, the patient received steroids, plasmapheresis, and zonisamide. He recovered well and was totally independent 6\u2009months after disease onset.<\/jats:p><jats:p>A cytokine profiler array kit was used to investigate neuroimmune mechanisms during the disease course. Several cytokines showed significant changes in plasma levels, such as B cell activating factor for B cell proliferation; thymus and activation-regulated chemokine for T cell chemoattraction; soluble CD40 ligand for Th2 cell mediation; C5\/C5a for complement activation; brain-derived neurotrophic factor for neuronal survival response; and dipeptidyl peptidase 4, retinol binding protein, dickkopf-related protein, and epidermal growth factor for response to environmental provocation. The concentration of cytokines was verified using Luminex multiplexing assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Due to their easy accessibility, blood cytokines are potential biomarkers of autoimmune encephalitis. Based on the investigating platform of this single case study, future larger scale studies are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12883-020-01879-x","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T08:04:09Z","timestamp":1597305849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cytokine changes during treatment of anti-Caspr2 encephalitis: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-3134","authenticated-orcid":false,"given":"Yi-Chia","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chieh","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"Pt 5","key":"1879_CR1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","volume":"135","author":"CG Bien","year":"2012","unstructured":"Bien CG, Vincent A, Barnett MH, Becker AJ, Blumcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135(Pt 5):1622\u201338.","journal-title":"Brain"},{"key":"1879_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","volume":"133","author":"J Bauer","year":"2016","unstructured":"Bauer J, Bien CG. Neuropathology of autoimmune encephalitides. Handb Clin Neurol. 2016;133:107\u201320.","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"1879_CR3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","volume":"18","author":"JP Camdessanche","year":"2011","unstructured":"Camdessanche JP, Streichenberger N, Cavillon G, Rogemond V, Jousserand G, Honnorat J, Convers P, Antoine JC. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol. 2011;18(6):929\u201331.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1879_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","volume":"72","author":"F Leypoldt","year":"2015","unstructured":"Leypoldt F, Hoftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostasy K, Schlumberger W, Meyer T, Wandinger KP, et al. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. JAMA Neurol. 2015;72(2):180\u20136.","journal-title":"JAMA Neurol"},{"key":"1879_CR5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2017.01.012","volume":"305","author":"B Deng","year":"2017","unstructured":"Deng B, Liu XN, Li X, Zhang X, Quan C, Chen XJ. Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: correlation with clinical outcome. J Neuroimmunol. 2017;305:84\u201391.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"1879_CR6","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","volume":"4","author":"AM Feyissa","year":"2017","unstructured":"Feyissa AM, Lopez Chiriboga AS, Britton JW. Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e353.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"1879_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.12174","volume":"141","author":"C Pei","year":"2014","unstructured":"Pei C, Barbour M, Fairlie-Clarke KJ, Allan D, Mu R, Jiang HR. Emerging role of interleukin-33 in autoimmune diseases. Immunology. 2014;141(1):9\u201317.","journal-title":"Immunology"},{"issue":"1","key":"1879_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.b.20021","volume":"61","author":"SS Khan","year":"2004","unstructured":"Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom. 2004;61(1):35\u20139.","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"1879_CR9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clim.2003.11.017","volume":"110","author":"E Morgan","year":"2004","unstructured":"Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol. 2004;110(3):252\u201366.","journal-title":"Clin Immunol"},{"issue":"7","key":"1879_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2(7):465\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1879_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","volume":"158","author":"I Moisini","year":"2009","unstructured":"Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol. 2009;158(2):155\u201363.","journal-title":"Clin Exp Immunol"},{"issue":"23","key":"1879_CR12","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","volume":"272","author":"T Imai","year":"1997","unstructured":"Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272(23):15036\u201342.","journal-title":"J Biol Chem"},{"issue":"3","key":"1879_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","volume":"107","author":"T Kakinuma","year":"2001","unstructured":"Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol. 2001;107(3):535\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1879_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1398-9995.2002.5720256.x","volume":"57","author":"T Sekiya","year":"2002","unstructured":"Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O, Sano Y, Morita A, Matsushima K, Hirai K. Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy. 2002;57(2):173\u20137.","journal-title":"Allergy"},{"issue":"1","key":"1879_CR15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev. 2009;229(1):152\u201372.","journal-title":"Immunol Rev"},{"issue":"3","key":"1879_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","volume":"26","author":"A Goules","year":"2006","unstructured":"Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun. 2006;26(3):165\u201371.","journal-title":"J Autoimmun"},{"issue":"5\u20136","key":"1879_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1034\/j.1600-0609.2002.02774.x","volume":"69","author":"M Nagahama","year":"2002","unstructured":"Nagahama M, Nomura S, Kanazawa S, Ozaki Y, Kagawa H, Fukuhara S. Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura. Eur J Haematol. 2002;69(5\u20136):303\u20138.","journal-title":"Eur J Haematol"},{"key":"1879_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","volume":"141","author":"JL Karnell","year":"2019","unstructured":"Karnell JL, Rieder SA, Ettinger R, Kolbeck R. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond. Adv Drug Deliv Rev. 2019;141:92\u2013103.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1879_CR19","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3):J276\u201386.","journal-title":"J Autoimmun"},{"issue":"2","key":"1879_CR20","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","volume":"2","author":"P Kortvelyessy","year":"2015","unstructured":"Kortvelyessy P, Bauer J, Stoppel CM, Bruck W, Gerth I, Vielhaber S, Wiedemann FR, Heinze HJ, Bartels C, Bien CG. Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e75.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"1879_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/NEN.0000000000000063","volume":"73","author":"A Klang","year":"2014","unstructured":"Klang A, Schmidt P, Kneissl S, Bago Z, Vincent A, Lang B, Moloney T, Bien CG, Halasz P, Bauer J, et al. IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies. J Neuropathol Exp Neurol. 2014;73(5):403\u201313.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1879_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","volume":"77","author":"E Martinez-Hernandez","year":"2011","unstructured":"Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology. 2011;77(6):589\u201393.","journal-title":"Neurology"},{"issue":"6","key":"1879_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn3505","volume":"14","author":"B Lu","year":"2013","unstructured":"Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14(6):401\u201316.","journal-title":"Nat Rev Neurosci"},{"issue":"Pt 8","key":"1879_CR24","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awq179","volume":"133","author":"RA Linker","year":"2010","unstructured":"Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Luhder F, et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain. 2010;133(Pt 8):2248\u201363.","journal-title":"Brain"},{"issue":"1\u20132","key":"1879_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2009.08.057","volume":"287","author":"L De Santi","year":"2009","unstructured":"De Santi L, Annunziata P, Sessa E, Bramanti P. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neurol Sci. 2009;287(1\u20132):17\u201326.","journal-title":"J Neurol Sci"},{"issue":"52","key":"1879_CR26","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","volume":"102","author":"R Aharoni","year":"2005","unstructured":"Aharoni R, Eilam R, Domev H, Labunskay G, Sela M, Arnon R. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci. 2005;102(52):19045\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"1879_CR27","first-page":"365083","volume":"2010","author":"DY Yap","year":"2010","unstructured":"Yap DY, Lai KN. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol. 2010;2010:365083.","journal-title":"J Biomed Biotechnol"},{"issue":"7","key":"1879_CR28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/096120330000900704","volume":"9","author":"E Trysberg","year":"2000","unstructured":"Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus. 2000;9(7):498\u2013503.","journal-title":"Lupus"},{"issue":"5","key":"1879_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","volume":"27","author":"H-Y Chun","year":"2007","unstructured":"Chun H-Y, Chung J-W, Kim H-A, Yun J-M, Jeon J-Y, Ye Y-M, Kim S-H, Park H-S, Suh C-H. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus Erythematosus. J Clin Immunol. 2007;27(5):461\u20136.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1879_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-016-0507-9","volume":"13","author":"Z Liba","year":"2016","unstructured":"Liba Z, Kayserova J, Elisak M, Marusic P, Nohejlova H, Hanzalova J, Komarek V, Sediva A. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. J Neuroinflammation. 2016;13(1):55.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"1879_CR31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archneur.65.10.1358","volume":"65","author":"S Ragheb","year":"2008","unstructured":"Ragheb S, Lisak R, Lewis R, Van Stavern G, Gonzales F, Simon K. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis. Arch Neurol. 2008;65(10):1358\u201362.","journal-title":"Arch Neurol"},{"issue":"6","key":"1879_CR32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mus.25162","volume":"54","author":"SY Kang","year":"2016","unstructured":"Kang SY, Kang CH, Lee KH. B-cell-activating factor is elevated in serum of patients with myasthenia gravis. Muscle Nerve. 2016;54(6):1030\u20133.","journal-title":"Muscle Nerve"},{"issue":"4","key":"1879_CR33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2016.10.017","volume":"167","author":"Y Li","year":"2016","unstructured":"Li Y, Oosting M, Smeekens SP, Jaeger M, Aguirre-Gamboa R, Le KTT, Deelen P, Ricano-Ponce I, Schoffelen T, Jansen AFM, et al. A functional genomics approach to understand variation in cytokine production in humans. Cell. 2016;167(4):1099\u20131110 e1014.","journal-title":"Cell"},{"key":"1879_CR34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fped.2017.00255","volume":"5","author":"ML Decker","year":"2017","unstructured":"Decker ML, Grobusch MP, Ritz N. Influence of age and other factors on cytokine expression profiles in healthy children-a systematic review. Front Pediatr. 2017;5:255.","journal-title":"Front Pediatr"},{"issue":"4","key":"1879_CR35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Ter Horst","year":"2016","unstructured":"Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, Kumar V, Diavatopoulos DA, Jansen AFM, Lemmers H, et al. Host and environmental factors influencing individual human cytokine responses. Cell. 2016;167(4):1111\u20131124 e1113.","journal-title":"Cell"},{"issue":"4","key":"1879_CR36","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, Ter Horst R, Jansen T, Jacobs L, Bonder MJ, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125\u20131136 e1128.","journal-title":"Cell"},{"key":"1879_CR37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcv.2017.02.007","volume":"89","author":"R Oliveira","year":"2017","unstructured":"Oliveira R, Cordeiro MT, Moura P, Baptista Filho PNB, Braga-Neto UM, Marques ETAJ, Gil L. Serum cytokine\/chemokine profiles in patients with dengue fever (DF) and dengue hemorrhagic fever (FHD) by using protein array. J Clin Virol. 2017;89:39\u201345.","journal-title":"J Clin Virol"},{"key":"1879_CR38","doi-asserted-by":"crossref","first-page":"1814304","DOI":"10.1155\/2019\/1814304","volume":"2019","author":"S Mihai","year":"2019","unstructured":"Mihai S, Codrici E, Popescu ID, Enciu AM, Rusu E, Zilisteanu D, Necula LG, Anton G, Tanase C. Inflammation-related patterns in the clinical staging and severity assessment of chronic kidney disease. Dis Markers. 2019;2019:1814304.","journal-title":"Dis Markers"},{"key":"1879_CR39","doi-asserted-by":"crossref","unstructured":"Balazs K, Kis E, Badie C, Bogdandi EN, Candeias S, Garcia LC, Dominczyk I, Frey B, Gaipl U, Juranyi Z, et al. Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients. Cancers (Basel). 2019;11(9).","DOI":"10.3390\/cancers11091324"},{"issue":"1","key":"1879_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","volume":"340","author":"F Chowdhury","year":"2009","unstructured":"Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale discovery, for human cytokine profiling. J Immunol Methods. 2009;340(1):55\u201364.","journal-title":"J Immunol Methods"},{"issue":"4","key":"1879_CR41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","volume":"38","author":"MF Elshal","year":"2006","unstructured":"Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods. 2006;38(4):317\u201323.","journal-title":"Methods"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01879-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T20:13:00Z","timestamp":1667765580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1879"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01879-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institution Review Board of Chang Medical Foundation (approval number 201700701A3).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient had signed the consent of publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}